Nantahala Capital Management, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for BENITEC BIOPHARMA INC. Common Stock, par value $0.0001 (BNTC)

Filing Manager
Nantahala Capital Management, LLC
Reporting Manager
Nantahala Capital Management, LLC
Security
BENITEC BIOPHARMA INC. Common Stock, par value $0.0001
Symbol
BNTC
Shares outstanding
23.7M shares
Disclosed Ownership
1.04M shares
Ownership
4.39%
Form type
SCHEDULE 13G/A
Filing time
15 May 2025, 16:38:23 UTC
Date of event
31 Mar 2025
Previous filing
14 Nov 2024
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nantahala Capital Management, LLC 4.39% 1.04M 0 1.04M /s/ Taki Vasilakis Taki Vasilakis / Chief Compliance Officer
Wilmot B. Harkey 4.39% 1.04M 0 1.04M /s/ Wilmot B. Harkey Wilmot B. Harkey
Daniel Mack 4.39% 1.04M 0 1.04M /s/ Daniel Mack Daniel Mack